Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
12 10 Search
2024
The molecular mechanism of MiR-26a-5p regulates autophagy and activates NLRP3 inflammasome to mediate cardiomyocyte hypertrophy
BMC Cardiovascular Disorders
2024
Epigenetic signatures in cardiac fibrosis: Focusing on noncoding RNA regulators as the gatekeepers of cardiac fibroblast identity
International Journal of Biological Macromolecules
2024
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease
Current Medicinal Chemistry
2023
Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression
Frontiers in Physiology
2023
MiR-423-5p Inhibition Exerts Protective Effects on Angiotensin II-Induced Cardiomyocyte Hypertrophy
The Tohoku Journal of Experimental Medicine
2022
Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
Frontiers in Cell and Developmental Biology
2021
MicroRNA-26a/b-5p promotes myocardial infarction-induced cell death by downregulating cytochrome c oxidase 5a
Experimental & Molecular Medicine
2021
Analysis of metabolomic and genomic markers for diagnosing cardiovascular diseases
Medical academic journal
2021
RNA binding Motif protein-38 regulates myocardial hypertrophy in LXR-α-dependent lipogenesis pathway
Bioengineered
2021
WITHDRAWN: MiR-140 suppresses airway inflammation and inhibits bronchial epithelial cell apoptosis in asthma by targeting GSK3β
Experimental and Molecular Pathology
Additional cited-by details will be shown when available from Crossref